Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

1.

Immunotherapy targeting glioma stem cells--insights and perspectives.

Li Z, Lee JW, Mukherjee D, Ji J, Jeswani SP, Black KL, Yu JS.

Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26. Review.

PMID:
22200324
[PubMed - indexed for MEDLINE]
2.

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.

Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE, Gottschalk S.

Clin Cancer Res. 2010 Jan 15;16(2):474-85. doi: 10.1158/1078-0432.CCR-09-1322. Epub 2010 Jan 12.

PMID:
20068073
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Frontiers in targeting glioma stem cells.

Frosina G.

Eur J Cancer. 2011 Mar;47(4):496-507. doi: 10.1016/j.ejca.2010.11.017. Epub 2010 Dec 22. Review.

PMID:
21185169
[PubMed - indexed for MEDLINE]
4.

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S.

Protein Cell. 2010 Jul;1(7):638-55. doi: 10.1007/s13238-010-0078-y. Epub 2010 Jul 29. Review.

PMID:
21203936
[PubMed - indexed for MEDLINE]
5.

Glioma stem cell research for the development of immunotherapy.

Ji J, Black KL, Yu JS.

Neurosurg Clin N Am. 2010 Jan;21(1):159-66. doi: 10.1016/j.nec.2009.08.006. Review.

PMID:
19944974
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.

Morgan RA, Johnson LA, Davis JL, Zheng Z, Woolard KD, Reap EA, Feldman SA, Chinnasamy N, Kuan CT, Song H, Zhang W, Fine HA, Rosenberg SA.

Hum Gene Ther. 2012 Oct;23(10):1043-53. doi: 10.1089/hum.2012.041. Epub 2012 Sep 24.

PMID:
22780919
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Targeting role of glioma stem cells for glioblastoma multiforme.

Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD, Hu SJ.

Curr Med Chem. 2013;20(15):1974-84. Review.

PMID:
23317162
[PubMed - indexed for MEDLINE]
8.

Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies.

Ahmed AU, Auffinger B, Lesniak MS.

Expert Rev Neurother. 2013 May;13(5):545-55. doi: 10.1586/ern.13.42. Review.

PMID:
23621311
[PubMed - indexed for MEDLINE]
9.

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.

Stem Cells. 2009 Aug;27(8):1734-40. doi: 10.1002/stem.102.

PMID:
19536809
[PubMed - indexed for MEDLINE]
Free Article
10.

New perspectives in glioma immunotherapy.

Daga A, Bottino C, Castriconi R, Gangemi R, Ferrini S.

Curr Pharm Des. 2011;17(23):2439-67. Review.

PMID:
21827420
[PubMed - indexed for MEDLINE]
11.

Targeting cancer stem cells through L1CAM suppresses glioma growth.

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.

Cancer Res. 2008 Aug 1;68(15):6043-8. doi: 10.1158/0008-5472.CAN-08-1079.

PMID:
18676824
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.

Poli A, Wang J, Domingues O, Planagumà J, Yan T, Rygh CB, Skaftnesmo KO, Thorsen F, McCormack E, Hentges F, Pedersen PH, Zimmer J, Enger PØ, Chekenya M.

Oncotarget. 2013 Sep;4(9):1527-46.

PMID:
24127551
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Targeting glioblastoma stem cells: cell surface markers.

He J, Liu Y, Lubman DM.

Curr Med Chem. 2012;19(35):6050-5. Review.

PMID:
22963566
[PubMed - indexed for MEDLINE]
14.

Glioma stem cell research for the development of immunotherapy.

Xu Q, Yuan X, Yu JS.

Adv Exp Med Biol. 2012;746:216-25. doi: 10.1007/978-1-4614-3146-6_17. Review.

PMID:
22639171
[PubMed - indexed for MEDLINE]
15.

Cell- and peptide-based immunotherapeutic approaches for glioma.

Yamanaka R.

Trends Mol Med. 2008 May;14(5):228-35. doi: 10.1016/j.molmed.2008.03.003. Epub 2008 Apr 9. Review.

PMID:
18403264
[PubMed - indexed for MEDLINE]
16.

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tønnesen P, Suso EM, Sæbøe-Larssen S, Sandberg C, Brinchmann JE, Helseth E, Rasmussen AM, Lote K, Aamdal S, Gaudernack G, Kvalheim G, Langmoen IA.

Cancer Immunol Immunother. 2013 Sep;62(9):1499-509. doi: 10.1007/s00262-013-1453-3. Epub 2013 Jul 2.

PMID:
23817721
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.

Allen C, Opyrchal M, Aderca I, Schroeder MA, Sarkaria JN, Domingo E, Federspiel MJ, Galanis E.

Gene Ther. 2013 Apr;20(4):444-9. doi: 10.1038/gt.2012.62. Epub 2012 Aug 23.

PMID:
22914495
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Targeting glioma stem cells: a novel framework for brain tumors.

Binello E, Germano IM.

Cancer Sci. 2011 Nov;102(11):1958-66. doi: 10.1111/j.1349-7006.2011.02064.x. Epub 2011 Sep 16. Review.

PMID:
21848914
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Immune therapeutic targeting of glioma cancer stem cells.

Hatiboglu MA, Wei J, Wu AS, Heimberger AB.

Target Oncol. 2010 Sep;5(3):217-27. doi: 10.1007/s11523-010-0151-8. Epub 2010 Aug 25. Review.

PMID:
20737294
[PubMed - indexed for MEDLINE]
20.

Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme.

Bregy A, Wong TM, Shah AH, Goldberg JM, Komotar RJ.

Cancer Treat Rev. 2013 Dec;39(8):891-907. doi: 10.1016/j.ctrv.2013.05.007. Epub 2013 Jun 21. Review.

PMID:
23790634
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk